Tinjauan Imunologi pada Fenomena Non-Responder terhadap Vaksinasi Hepatitis B
Analisis
DOI:
https://doi.org/10.55175/cdk.v52i4.1437Kata Kunci:
Vaksin hepatitis B, respons imun, non-responderAbstrak
Vaksin Hepatitis B sangat efektif mencegah infeksi HBV. Namun, beberapa individu yang disebut kelompok non-responden gagal mencapai titer antibodi yang memadai (anti-HBs ≥ 10 mIU/mL) setelah vaksinasi lengkap. Fenomena non-responden dipengaruhi oleh interaksi kompleks antara faktor genetik, imunologi, dan lingkungan. Tinjauan pustaka ini bertujuan untuk menelaah aspek imunologi fenomena non-responden, mengeksplorasi faktor-faktor yang memengaruhi respons vaksin, mekanisme imunologi yang terlibat, dan langkah untuk mengatasi fenomena non-responder.
Unduhan
Referensi
Trepo C, Chan HLY, Lok A. Hepatitis B virus infection. Lancet. 2014;384(9959):2053–63. DOI: 10.1016/S0140-6736rnet]. 20(14)60220-8.
Hepatitis B [Inte24 Apr 09 [cited 2024 Jul 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B virus: Advances in prevention, diagnosis, and therapy. Clin Microbiol Rev. 2020;33(2):1–38. DOI: 10.1128/CMR.00046-19.
Poorolajal J, Hooshmand E. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2016;(6):CD008256. DOI: 10.1002/14651858.CD008256.pub3.
Wiesen E, Lagani W, Sui G, Arava J, Reza S, Diorditsa S, et al. Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014. Vaccine. 2016;34(3):367–72. DOI: 10.1016/j.vaccine.2015.11.044.
Bianchi FP, Stefanizzi P, Migliore G, Martinelli A, Vimercati L, Germinario CA, et al. Prevalence of healthcare workers fully vaccinated against hepatitis B without circulating antibodies in Italy and role of age at baseline cycle vaccination: A systematic review and meta-analysis. Expert Rev Vaccines 2023;22(1):139–47. DOI: 10.1080/14760584.2023.2162507.
Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: The Chinese experience. Chin Med J (Engl). 2009;122(1):98–102. PMID: 19187625.
Elrashidy H, Elbahrawy A, El-Didamony G, Mostafa M, George NM, Elwassief A, et al. Antibody levels against hepatitis B virus after hepatitis B vaccination in Egyptian diabetic children and adolescents. Hum Vaccin Immunother. 2013;9(9):2002–6. DOI: 10.4161/hv.25426.
Lebosse F, Zoulim F. Hepatitis B vaccine and liver cancer. Bull Cancer 2021;108(1):90–101. DOI: 10.1016/j.bulcan.2020.10.014.
Leidner AJ, Murthy N, Chesson HW, Biggerstaff M, Stoecker C, Harris AM, et al. Cost-effectiveness of adult vaccinations: A systematic review. Vaccine. 2019;37(2):226–34. DOI: 10.1016/j.vaccine.2018.11.056.
Zhao M, Li X, Xie S, Gong M, Yan R, Zheng A, et al. The dynamics and association of B and T cell receptor repertoires upon antibody response to hepatitis B vaccination in healthy adults. Hum Vaccin Immunother. 2021;17(9):3203–13. DOI: 10.1080/21645515.2021.1913028.
Trevisan A, Mason P, Nicolli A, Maso S, Fonzo M, Scarpa B, et al. Future healthcare workers and hepatitis b vaccination: A new generation. Int J Environ Res Public Health 2021;18(15):1–9. DOI: 10.3390/ijerph18157783.
Bayhan GI, Balli SE, Demir H, Baydar Z. How does the immunogenicity of hepatitis B vaccine change over the years in childhood? Hum Vaccin Immunother. 2021;17(8):2768–72. DOI: 10.1080/21645515.2021.1902724.
Ren W, Ren J, Wu Z, Shen L, Shan H, Dai X, et al. Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results. Hum Vaccin Immunother. 2020;16(3):687–92. DOI: 10.1080/21645515.2019.1666612.
Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin Drug Saf. 2003;2(2):113–22. DOI: 10.1517/14740338.2.2.113.
Yao J, Li J, Chen Y, Shan H, Dai XW, Yang LN, et al. The response of hepatitis B vaccination on seronegative adults with different vaccination schedules. Hum Vaccin Immunother. 2015;11(5):1102–7. DOI: 10.4161/21645515.2014.985500.
Filippelli M, Lionetti E, Gennaro A, Lanzafame A, Arrigo T, Salpietro C, et al. Hepatitis B vaccine by intradermal route in non responder patients: An update. World J Gastroenterol. 2014;20(30):10383–94. DOI: 10.3748/wjg.v20.i30.10383.
Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, et al. Prevention of hepatitis B infections: Vaccination and its limitations. Acta Clin Belg. 2001;56(4):209–19. DOI: 10.1179/acb.2001.032.
Gehring AJ, Mendez P, Richter K, Ertl H, Donaldson EF, Mishra P, et al. Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection. J Hepatol. 2022;77(2):525–38. DOI: 10.1016/j.jhep.2022.02.020.
Gorczynski R, Stanley J. Clinical immunology. 1st Ed. Clinical immunology. Texas: Vademecum; 2013.
Lang PO, Govind S, Michel JP, Aspinall R, Mitchell WA. Immunosenescence: Implications for vaccination programmes in adults. Maturitas. 2011;68:322–30.
Trevisan A, Frasson C, De Nuzzo D, Nicolli A, Scapellato ML. Significance of anti-HB levels below 10 IU/L after vaccination against hepatitis B in infancy or adolescence: An update in relation to sex. Hum Vaccin Immunother. 2020;16(2):460–4. DOI: 10.1080/21645515.2019.1656483.
Resende VLS, Abreu MHG, Paiva SM, Teixeira R, Pordeus IA. Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists. Virol J. 2010;7:1–9. DOI: 10.1186/1743-422X-7-154.
Sokoya T, Steel HC, Nieuwoudt M, Rossouw TM. HIV as a cause of immune activation and immunosenescence. Mediators Inflamm. 2017;2017(Il):100–16. DOI: 10.1155/2017/6825493.
Calleja-Conde J, Echeverry-Alzate V, Buhler KM, Duran-Gonzalez P, Morales-García JA, Segovia-Rodriguez L, et al. The immune system through the lens of alcohol intake and gut microbiota. Int J Mol Sci. 2021;22(14):1–15. DOI: 10.3390/ijms22147485.
Yang S, Tian G, Cui Y, Ding C, Deng M, Yu C, et al. Factors influencing immunologic response to hepatitis B vaccine in adults. Sci Rep. 2016;6:1–12. DOI: 10.1038/srep27251.
Ismailova A, White JH. Vitamin D, infections and immunity. Rev Endocr Metab Disord. 2022;23(2):265–77. DOI: 10.1007/s11154-021-09679-5.
Munteanu C, Schwartz B. The relationship between nutrition and the immune system. Front Nutr. 2022;9:1–23. DOI: 10.3389/fnut.2022.1082500.
Mani SKK, Andrisani O. Interferon signaling during hepatitis B virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine 2019;124:1–19. DOI: 10.1016/j.cyto.2018.08.012.
Chang J, Block TM, Guo JT. The innate immune response to hepatitis B virus infection: Implications for pathogenesis and therapy. Antiviral Res. 2012;96(3):405–13. DOI: 10.1016/j.antiviral.2012.10.001.
Farooq PD, Sherman KE. Hepatitis B vaccination and waning hepatitis B immunity in persons living with HIV. Curr HIV/AIDS Rep. 2019;16(5):395–403. DOI: 10.1007/s11904-019-00461-6.
Lee GH, Lim SG. CpG-adjuvanted hepatitis B vaccine (HEPLISAV-B®) update. Expert Rev Vaccines. 2021;20(5):487–95. DOI: 10.1080/14760584.2021.1908133.
Veiga APR, Casseb J, Duarte AJS. Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naive) and CD45RO+ (memory) subsets in HIV-1-infected subjects. Vaccine. 2006;24(49–50):7124–8. DOI: 10.1016/j.vaccine.2006.06.079.
Filippelli M, Lionetti E, Gennaro A, Lanzafame A, Arrigo T, Salpietro C, et al. Hepatitis B vaccine by intradermal route in non responder patients: An update. World J Gastroenterol. 2014;20(30):10383–94. DOI: 10.3748/wjg.v20.i30.10383.
Walayat S, Ahmed Z, Martin D, Puli S, Cashman M, Dhillon S. Recent advances in vaccination of non-responders to standard dose hepatitis B virus vaccine. World J Hepatol. 2015;7(24):2503–9. DOI: 10.4254/wjh.v7.i24.2503.
Di Lello FA, Martinez AP, Flichman DM. Insights into induction of the immune response by the hepatitis B vaccine. World J Gastroenterol. 2022;28(31):4249–62. DOI: 10.3748/wjg.v28.i31.4249.
Wing JB, Sakaguchi S. Foxp3+ Treg cells in humoral immunity. Int Immunol. 2014;26(2):61–9. DOI: 10.1093/intimm/dxt060.
Kwan BS, Shim SG, Cho DH, Kim KM, Choi IS, Lee DG. Immune response to hepatitis B vaccination and factors associated with poor immune response among healthcare workers. Niger J Clin Pract. 2021;24(6):795–801. DOI: 10.4103/njcp.njcp_187_19.
Sullivan KE, Cutilli J, Piliero LM, Ghavimi-Alagha D, Starr SE, Campbell DE, et al. Measurement of cytokine secretion, intracellular protein expression, and mRNA in resting and stimulated peripheral blood mononuclear cells. Clin Vaccine Immunol. 2000;7(6):920–4. DOI: 10.1128/CDLI.7.6.920-924.2000.
Abara WE, Qaseem A, Schillie S, McMahon BJ, Harris AM, High value care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention, et al. Hepatitis B vaccination, screening, and linkage to care: Best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804. DOI: 10.7326/M17-1106.
Pan J, Yao T, Cheng H, Zhu Y, Wang Y. B lymphocyte-mediated humoral immunity in the pathogenesis of chronic hepatitis B infection. Liver Res. 2020;4(3):124–8. DOI: 10.1016/j.livres.2020.07.001.
Plotkin S, Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011;53(1):68–75. DOI: 10.1093/cid/cir270.
Tajiri K, Shimizu Y. Unsolved problems and future perspectives of hepatitis B virus vaccination. World J Gastroenterol. 2015;21(23):7074–83. DOI: 10.3748/wjg.v21.i23.7074.
Lusida MI, Juniastuti, Yano Y. Current hepatitis B virus infection situation in Indonesia and its genetic diversity. World J Gastroenterol. 2016;22(32):7264. DOI: 10.3748/wjg.v22.i32.7264.
Doi H, Kanto T. Factors influencing the durability of hepatitis B vaccine responses. Vaccine 2021;39(36):5224–30. DOI: 10.1016/j.vaccine.2021.07.017.
Wei KP, Zhu FC, Liu JX, Yan L, Lu Y, Zhai XJ, et al. The efficacy of two different dosages of hepatitis B immunoglobulin combined with hepatitis B vaccine in preventing mother-to-child transmission of hepatitis B virus: A prospective cohort study. Vaccine 2018;36(2):256–63. DOI: 10.1016/j.vaccine.2017.11.037.
Rahmani A, Montecucco A, Kusznir Vitturi B, Debarbieri N, Dini G, Durando P. Long-term effectiveness of hepatitis B vaccination in the protection of healthcare students in highly developed countries: A systematic review and meta-analysis. Vaccines (Basel). 2022;10(11):1–18. DOI: 10.3390/vaccines10111841.
Spellman S, Warden MB, Haagenson M, Pietz BC, Goulmy E, Warren EH, et al. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants. Biol Blood Marrow Transplant. 2009;15(7):856–63. DOI: 10.1016/j.bbmt.2009.03.018.
Wang LY, Chen CF, Wu TW, Lai SK, Chu CC, Lin HH. Response to hepatitis B vaccination is co-determined by HLA-DPA1 and -DPB1. Vaccine 2019;37(43):6435–40. DOI: 10.1128/CMR.00046-19.
Unduhan
Diterbitkan
Cara Mengutip
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2025 Adika Zhulhi Arjana, Ninda Devita
Artikel ini berlisensi Creative Commons Attribution-NonCommercial 4.0 International License.
